Prognostic significance of natural killer cell activity in patients with laryngeal carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 8, 1998, Pages 852-856

  González, Francisco M ^a   Vargas, Juan A ^a   López Cortijo, Cristóbal ^a   Castejón, Raquel ^a   Gorriz, Carmen ^a   Ramírez Camacho, Rafael ^a   Millán, Isabel ^a   Durántez, Alberto ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0031820454     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.8.852     Document Type: Article

References (35)

1. Smee R, Bridger GP, eds. Laryngeal Cancer. Amsterdam, the Netherlands: Elsevier Science Publishers; 1994.
2. Peters L. The problem with the present staging and classification of laryngeal cancer. In: Smee R, Bridger GP, eds. Laryngeal Cancer. Amsterdam, the Netherlands: Elsevier Science Publishers; 1994:241-243.
3. Bridger GP. Staging the glottis and subglottis. In: Smee R, Bridger GP, eds. Laryngeal Cancer. Amsterdam, the Netherlands: Elsevier Science Publishers; 1994: 253-261.
4. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1988;47:187-376.
5. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today. 1988;9:291-293.
6. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of NK cells in tumour growth and metastasis in beige mice. Nature. 1980;284:622-624.
7. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia, Pa: JB Lippincott 1992.
8. International Union Against Cancer. TNM Classification of Malignant Tumours. 4th ed. 2nd rev. Berlin, Germany: Springer-Verlag; 1992.
9. Weber RS. Chemotherapy trials in head and neck cancer: where are we, and where are we going? Head Neck. 1994;16:528-529.
10. International Union Against Cancer. TNM Supplement: A Commentary on Uniform Use. Berlin, Germany: Springer-Verlag; 1993.
11. Ferlito A. The World Health Organization's revised classification of tumours of the larynx, hypopharynx, and trachea. Ann Otol Rhinol Laryngol. 1993;102: 666-669.
12. Schantz SP. Biologic staging of head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 1993;1:107-113.
13. Ferlito A, Harrison DFN, Bailey BJ, et al. Are clinical classifications for laryngeal carcinoma satisfactory? Ann Otol Rhinol Laryngol. 1995;104:741-747.
14. Piccirillo JF. Purposes, problems and proposals for progress in cancer staging. Arch Otolaryngol Head Neck Surg. 1995;121:145-149.
15. Vlock DR. Immunobiologic aspects of head and neck cancer. Hematol Oncol Clin North Am. 1991;5:797-820.
16. Gonzalez FM, Vargas JA, Gea-Banacloche JC, et al. Functional and phenotypic analysis of T-lymphocytes in laryngeal carcinoma. Acta:Otolaryngol (Stockh). 1994; 114:663-668.
17. Pross HF, Lotzova E. Role of natural killer cells in cancer. Nat Immun. 1993;12: 279-292.
18. Carballido J, Alvarez-Mon M, Solovera J, et al. Clinical:significance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol. 1990; 143:29-33.
19. Strayer DR, Carter WEA, Mayberry SO. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer Res. 1984;44:370-373.
20. LeFever AV, Funahashi A. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. Cancer Res. 1991;51:5596-5601.
21. Kumazawa H, Mess M. Influence of serum derived from patients with head and neck cancer on natural killer cell activity. Oncology. 1991;48:372-376.
22. Schantz SP, Campbell BH, Guillamondegui OM. Pharyngeal carcinoma and natural killer cell activity. Am J Surg. 1986;152:467-474.
23. Aparicio-Pages NM, Verspaget HW, Pena SA, et al. Impaired local natural killer cell activity in human colorectal carcinomas. Cancer Immunol Immunother. 1989; 28:301-304.
24. Wustrow TPU, Zenner HP. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx. Laryngoscope. 1985;95:1391-1399.
25. Schantz SP, Liu FJ. An immunological profile of young adults with head and neck cancer. Cancer. 1989;64:1232-1237.
26. Schantz SP, Peters LJ. Patterns of recurrence from head and neck cancer: an immunologic perspective. Am J Clin Oncol. 1987;10:469-474.
27. González FM, Vargas JA, Lacoma F, et al. Natural killer cell activity in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1993;119:69-72.
28. Schantz SP, Goepfert H. Multimodality therapy and distant metastases: the impact of natural killer cell activity. Arch Otolaryngol Head Neck Surg. 1987;112:545-551.
29. González FM, Vargas JA, Gea-Banacloche JC, et al. Study of spontaneous cytotoxic activity in laryngeal carcinoma: prognostic value. Acta Otorhinolaryngol Esp. 1995;46:431-436.
30. Brittenden J, Heys SD, Ross J, et al. Natural killer cells and cancer. Cancer. 1996; 77:1226-1243.
31. Whiteside TL, Herberman RB. Role of the natural killer cells in health and disease. Clin Diagn Lab Immunol. 1994;1:125-133.
32. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol. 1995;7:704-710.
33. Schantz SP, Savage HE, Racz T, et al. Natural killer cells and metastases from pharyngeal carcinoma. Am J Surg. 1989;158:361-366.
34. Schantz SP, Ordonez NG. Quantification of a natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat Immun Cell Growth Regul. 1993;10:278-288.
35. Hersey P, Edwards A, Milton GW,et al. No evidence for an association between natural killer cell activity and prognosis in melanoma patients. Nat Immun Cell Growth Regul. 1984;3:1-6.